Precursors of Cardiovascular Disease and Emerging Strategies With StatinsCMEDyslipidemia is only one signal of cardiovascular disease (CVD) risk. Inflammation is a frequent precursor of cardiac-related events. Drs. Willerson, Ballantyne, and Ridker critically examine the mechanisms of atherosclerosis, elevated C-reactive protein and other risk factors, and statin therapy to preemptively address or ameliorate CVD.
MedscapeCME Ob/Gyn & Women's Health, November 2009
Lipid Insights from the AHA 2009CMEDr. Michael Davidson will lead a targeted discussion focusing on the interpretation and application of results presented at this year's AHA meeting. Joining him will be Dr. Christie Ballantyne, Dr. Vera Bittner and Dr. Roger Blumenthal.
Treating Atrial Fibrillation: A Multidisciplinary ApproachCME/CERate control, rhythm control, new drugs and devices for anticoagulation -- the armamentarium of treatment options is expanding rapidly. Drs. Yancy, Cannon, and Boehmer discuss the latest treatment modalities for patients with AF.
MedscapeCME Neurology & Neurosurgery, November 2009
Risk Stratification in Hematologic MalignanciesCME/CEDrs. Kanti R. Rai and Steven E. Coutre address the latest risk stratification strategies for patients with a variety of hematologic malignancies.
NCCN - MedscapeCME Metastatic Colorectal Cancer Tumor BoardCME/CEIn this video roundtable, Drs. Alan Venook, Mary Mulcahy, and Michael Choti illustrate the process of treatment decision making as they "think through" 2 complex patient cases.